Department of Psychiatry and Psychotherapy, University Hospital Zurich, Switzerland.
Eur J Psychotraumatol. 2012;3. doi: 10.3402/ejpt.v3i0.17660. Epub 2012 Jun 25.
Many traumatised refugees suffer from both persistent pain and posttraumatic stress disorder (PTSD). To date, no specific guidelines exist for treatment of this group of patients. This paper presents data on a pilot treatment study conducted with 15 traumatised refugees with persistent pain and PTSD.
Participants received 10 sessions of pain-focused treatment with biofeedback (BF) followed by 10 sessions of Narrative Exposure Therapy (NET). Structured interviews and standardised questionnaires were used to assess symptoms of pain intensity, pain disability, PTSD and quality of life directly before and after treatment and at 3 months follow-up.
Following the combined intervention, participants showed a significant reduction in both pain and PTSD symptoms, as well as improved quality of life. Additionally, biofeedback increased motivation for subsequent trauma-focused therapy, which in turn was related to larger PTSD treatment gains.
This pilot study provides initial evidence that combining BF and NET is safe, acceptable, and feasible in patients with co-morbid persistent pain and PTSD.
许多创伤后难民既患有持续性疼痛又患有创伤后应激障碍(PTSD)。迄今为止,尚无针对这组患者的具体治疗指南。本文介绍了对 15 名患有持续性疼痛和 PTSD 的创伤后难民进行的一项试点治疗研究的数据。
参与者接受了 10 次以生物反馈(BF)为重点的疼痛治疗,随后进行了 10 次叙事暴露疗法(NET)。在治疗前后和 3 个月随访时,使用结构化访谈和标准化问卷直接评估疼痛强度、疼痛残疾、PTSD 和生活质量的症状。
联合干预后,参与者的疼痛和 PTSD 症状均显著减轻,生活质量得到改善。此外,生物反馈增加了对随后创伤聚焦治疗的动机,而这反过来又与更大的 PTSD 治疗效果相关。
这项试点研究初步证明,在患有共病持续性疼痛和 PTSD 的患者中,结合 BF 和 NET 是安全、可接受且可行的。